AMENDED & RESTATED LICENSE AGREEMENTLicense Agreement • May 10th, 2018 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2018 Company Industry JurisdictionTHIS AMENDED & RESTATED LICENSE AGREEMENT (the “Agreement”), effective as of this 17th day of March, 2008 (the “Effective Date”), by and between Panion & BF Biotech, Inc., with offices at 16F No. 3, Yuanqu Street, Nangang District, Taipei, Taiwan, ROC (hereinafter "Licensor"), and Keryx Biopharmaceuticals, Inc, with offices at 750 Lexington, 20th Floor, New York, NY 10022 (hereinafter "Licensee").
AMENDED & RESTATED LICENSE AGREEMENTLicense Agreement • May 12th, 2008 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 12th, 2008 Company Industry JurisdictionTHIS AMENDED & RESTATED LICENSE AGREEMENT (the “Agreement”), effective as of this 17th day of March, 2008 (the “Effective Date”), by and between Panion & BF Biotech, Inc., with offices at 16F No. 3, Yuanqu Street, Nangang District, Taipei, Taiwan, ROC (hereinafter "Licensor"), and Keryx Biopharmaceuticals, Inc, with offices at 750 Lexington, 20th Floor, New York, NY 10022 (hereinafter "Licensee").
LICENSE AGREEMENTLicense Agreement • May 17th, 2006 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2006 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”), effective as of this 7th day of November 2005 (the “Effective Date”), by and between Panion & BF Biotech, Inc., with offices at 16F No. 3, Yuanqu Street, Nangang District, Taipei, Taiwan, ROC (hereinafter "Licensor"), and Keryx Biopharmaceuticals, Inc, with offices at 750 Lexington, 20th Floor, New York, NY 10022 (hereinafter "Licensee").
LICENSE AGREEMENTLicense Agreement • May 10th, 2006 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2006 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”), effective as of this 7th day of November 2005 (the “Effective Date”), by and between Panion & BF Biotech, Inc., with offices at 16F No. 3, Yuanqu Street, Nangang District, Taipei, Taiwan, ROC (hereinafter "Licensor"), and Keryx Biopharmaceuticals, Inc, with offices at 750 Lexington, 20th Floor, New York, NY 10022 (hereinafter "Licensee").
LICENSE AGREEMENTLicense Agreement • March 8th, 2006 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 8th, 2006 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”), effective as of this 7th day of November 2005 (the “Effective Date”), by and between Panion & BF Biotech, Inc., with offices at 16F No. 3, Yuanqu Street, Nangang District, Taipei, Taiwan, ROC (hereinafter "Licensor"), and Keryx Biopharmaceuticals, Inc, with offices at 750 Lexington, 20th Floor, New York, NY 10022 (hereinafter "Licensee").